Know that digoxin has a narrow therapeutic window with several complications and toxicities
Know that digoxin has a narrow therapeutic window with several complications and toxicities: Excerpt from Avoiding Common Pediatric Errors
Author:
Mindy Dickerman, MD
What to Do - Interpret the Data, Take Action
Obtaining digoxin levels in specific circumstances can be lifesaving.
Digoxin is the most widely used cardiac glycoside. These agents
inhibit the sodium-potassium-adenosine triphosphate (Na+-K+ATPase)
pump and, therefore, block active transport of Na+ and K+ across cell membranes. Increased intracellular Na+ reduces the transmembrane Na+ gradient and subsequently increases activity of the Na+-Ca+ exchanger, which
causes intracellular calcium to rise. It is this increased intracellular Ca+ that
augments myofibril activity in cardiac myocytes, causing a positive inotropic
actionand therefore isusedfortreatmentofcongestiveheartfailure.Digoxin
is also used to slow the ventricular rate in certain tachyarrhythmias.
Digoxin can cause toxicity by increasing vagal tone that may lead to
direct atrioventricular depression and arrhythmias. Clinically, a patient may
present with acute or chronic digoxin toxicity. There are several dysrhythmias that can result, most commonly frequent premature ventricular beats.
Bidirectional ventricular tachycardia is specific for digoxin toxicity but is
rarely seen. Noncardiac symptoms of toxicity may include anorexia, nausea,
vomiting headache, fatigue, depression, dizziness, confusion, memory loss,
delirium, and hallucinations. Visual disturbances, specifically xanthopsia,
seeing yellow halos around objects, have been reported. Vague symptoms
can lead to a misdiagnosis of viral syndrome, so a high degree of suspicion
must be maintained. Chronic toxicity may lead to renal failure.
Digoxin toxicity can occur if a condition or medication changes the
metabolism or excretion of the drug. This can happen if a patient is in
renal failure. Some of the medications that can affect digoxin metabolism
include quinidine, cyclosporine, verapamil, tetracycline, erythromycin, and
rifampin.
If you suspect your patient has digoxin toxicity, immediately place the
patient on a cardiac monitor. Bradycardia is the most common vital sign
change. If stable, these patients should have an electrocardiogram performed
and a chemistry and digoxin level drawn. Hyperkalemia will usually be seen
in acute toxicity due to the inhibition of the Na+-K+-ATPase and a resultant
rise in extracellular K+. Hyperkalemia may not be seen in chronic digoxin
toxicity because the kidneys had time to compensate or the patient is on
diuretics that promote potassium excretion.
Serum digoxin levels need to be interpreted with caution. High levels
do not always indicate toxicity. In the case of an acute exposure, digoxin
will slowly redistribute into the tissues after it is absorbed in the plasma.
False-positive results may occur in the presence of digoxin, such as immunoreactive substances, which can be seen in neonates, pregnancy, and
other disease states. Therapeutic levels in children are reported between
0.5 and 2.0 ng/mL. Levels >10 ng/mL may be associated with significant
toxicity and treatment with digoxin-specific Fab should be considered.
Ifapatientwithdigoxintoxicityhascardiacdysrhythmiaswithhemodynamic instability, Fab fragments are first-line therapy Digoxin-specific Fab
fragments are antibody fragments produced by enzymatic cleavage of sheep
immunoglobulin G antibodies to digoxin. Several antiarrhythmics have been
used to treat digoxin toxicity associated dysrhythmias. Antiarrhythmics that
depress atrioventricular nodal conduction are contraindicated because they
can worsen cardiac toxicity. If there has been an acute ingestion within 6 to
8 hours, charcoal can be administered for gastrointestinal decontamination.
Intravenous potassium and magnesium may be beneficial in patients with
chronic digoxin toxicity. Calcium and beta blockers should be avoided. Electrical cardioversion should be performed with extreme caution and as a last
resort.
Suggested Readings
Antman EM, Wenger TL, Butler VP Jr, et al. Treatment of 150 cases of life-threatening digitalis
intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter
study. Circulation. 1990;81:1744–1752.
Morris SA, Hatcher HF, Reddy DK. Digoxin therapy for heart failure: an update. Am Fam
Physician. 2006;74:613–618.
Book Source Details
- Book Title: Avoiding Common Pediatric Errors
- Author(s): Anthony D Slonim MD, DrPH; Lisa Marcucci MD
- Year of Publication: 2008
- Copyright Details: Avoiding Common Pediatric Errors, Copyright © 2008 Lippincott Williams & Wilkins.
More About Stevens-Johnson Syndrome
More Medical Textbooks Online about Stevens-Johnson Syndrome
Review other book chapters online related to Stevens-Johnson Syndrome:
Medical Books Excerpts
- Erythema
- "Handbook of Signs & Symptoms (Third Edition)" (2006)
- [ read ]
- Stomatitis
- "The 10-Minute Diagnosis Manual: Symptoms and Signs in the Time-Limited Encounter" (2000)
- [ read ]
- Erythema Multiforme
- "The 10-Minute Diagnosis Manual: Symptoms and Signs in the Time-Limited Encounter" (2000)
- [ read ]
- Erythema
- "Alarming Signs and Symptoms: Lippincott Manual of Nursing Practice Series" (2007)
- [ read ]
- Erythema
- "Signs & Symptoms: A 2-in-1 Reference for Nurses" (2007)
- [ read ]
Copyright notice for book excerpts: Copyright © 2008 Lippincott Williams & Wilkins. All rights reserved.
|
|
More About This Book:
Title: Avoiding Common Pediatric Errors
Authors: Anthony D Slonim MD, DrPH; Lisa Marcucci MD
Publisher: Lippincott Williams & Wilkins
Copyright: 2008
ISBN: 0-7817-7489-6
|
|
» Next page: Recognize tricyclic antidepressant (TCA) toxicity and manage itaggressively (Avoiding Common Pediatric Errors)
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: